These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3373603)

  • 1. Gouty diathesis and sarcoidosis in patient with recurrent calcium nephrolithiasis.
    Harvey JA; Pak CY
    J Urol; 1988 Jun; 139(6):1287-9. PubMed ID: 3373603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment of calcium nephrolithiasis with potassium citrate.
    Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
    J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical metabolic characteristics for calcium oxalate stone formation in patients with gouty diathesis.
    Pak CY; Moe OW; Sakhaee K; Peterson RD; Poindexter JR
    J Urol; 2005 May; 173(5):1606-9. PubMed ID: 15821508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
    Preminger GM; Sakhaee K; Skurla C; Pak CY
    J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.
    Barcelo P; Wuhl O; Servitge E; Rousaud A; Pak CY
    J Urol; 1993 Dec; 150(6):1761-4. PubMed ID: 8230497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can citrate therapy prevent nephrolithiasis?
    Abdulhadi MH; Hall PM; Streem SB
    Urology; 1993 Mar; 41(3):221-4. PubMed ID: 8442301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.
    Pak CY; Peterson R; Sakhaee K; Fuller C; Preminger G; Reisch J
    Am J Med; 1985 Sep; 79(3):284-8. PubMed ID: 4036979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
    Pak CY; Fuller C
    Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful management of uric acid nephrolithiasis with potassium citrate.
    Pak CY; Sakhaee K; Fuller C
    Kidney Int; 1986 Sep; 30(3):422-8. PubMed ID: 3784284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate.
    Preminger GM; Sakhaee K; Pak CY
    J Urol; 1988 Feb; 139(2):240-2. PubMed ID: 3339718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY; Peterson R
    Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: changes produced by food-magnesium interaction.
    Lindberg J; Harvey J; Pak CY
    J Urol; 1990 Feb; 143(2):248-51. PubMed ID: 2299712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine citrate and renal stone disease.
    Goldberg H; Grass L; Vogl R; Rapoport A; Oreopoulos DG
    CMAJ; 1989 Aug; 141(3):217-21. PubMed ID: 2665909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.